Literature DB >> 12558760

The association between migraine and juvenile stroke: a case-control study.

Sonja Schwaag1, Darius G Nabavi, Achim Frese, Ingo-W Husstedt, Stefan Evers.   

Abstract

BACKGROUND: Several studies suggest an association between migraine and juvenile stroke. Because of some shortcomings, we designed another case-control study of a homogenous group of patients with juvenile cerebral ischemia. This study is part of a larger German epidemiological research project on the association of migraine with cerebrovascular disease.
METHODS: We enrolled 160 consecutive patients under the age of 46 years with first-ever ischemic stroke or transient ischemic attack and 160 strictly sex- and age-matched controls. Patients suffering from arterial dissection, brain hemorrhage, cranial sinus thrombosis, lacunar stroke, or from migrainous infarction were excluded. Migraine was diagnosed according to the criteria of the International Headache Society by the same 2 independent interviewers. For analyzing the data, nonparametric statistical methods including odds ratio and 95% confidence interval were used.
RESULTS: Migraine was a significant risk factor for juvenile stroke for the total sample with an odds ratio of 2.11 (confidence interval, 1.16 to 3.82). The odds ratio was even higher in the subgroup under the age of 35 (3.26) and in the female subgroup (2.68). We found migraine to be independent from other vascular risk factors, from etiology, and from the territory of stroke.
CONCLUSION: We can confirm the findings of previous studies showing a significant association between migraine and juvenile stroke in women. Furthermore, our data suggest migraine to be an even more significant risk factor for patients under the age of 35 and to be independent from other vascular risk factors.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12558760     DOI: 10.1046/j.1526-4610.2003.03023.x

Source DB:  PubMed          Journal:  Headache        ISSN: 0017-8748            Impact factor:   5.887


  22 in total

Review 1.  Risk of ischaemic stroke in people with migraine: systematic review and meta-analysis of observational studies.

Authors:  Mahyar Etminan; Bahi Takkouche; Francisco Caamaño Isorna; Ali Samii
Journal:  BMJ       Date:  2004-12-13

2.  Migrainous cerebral infarction triggered by alcohol intake under the burning sun.

Authors:  Sachiyo Matsuo; Yasuo Suzuki; Masato Hashimoto; Kenji Ohtsuka
Journal:  Jpn J Ophthalmol       Date:  2006 Jul-Aug       Impact factor: 2.447

Review 3.  Patent foramen ovale and migraine: association, causation, and implications of clinical trials.

Authors:  Stewart J Tepper; Catalina Cleves; Frederick R Taylor
Journal:  Curr Pain Headache Rep       Date:  2009-06

Review 4.  Antithrombotic therapy for stroke in young adults.

Authors:  Jeremy R Payne; Bruce Coull
Journal:  J Thromb Thrombolysis       Date:  2005-10       Impact factor: 2.300

Review 5.  [Non-alimentary trigger factors of migraine and tension-type headache].

Authors:  J Holzhammer; C Wöber
Journal:  Schmerz       Date:  2006-06       Impact factor: 1.107

Review 6.  The risk of stroke in patients with migraine and implications for migraine management.

Authors:  Gretchen E Tietjen
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

7.  Age-specific association of migraine with cryptogenic TIA and stroke: Population-based study.

Authors:  Linxin Li; Ursula G Schulz; Wilhelm Kuker; Peter M Rothwell
Journal:  Neurology       Date:  2015-09-30       Impact factor: 9.910

Review 8.  Migraine-associated risks and comorbidity.

Authors:  H C Diener; M Küper; T Kurth
Journal:  J Neurol       Date:  2008-09-30       Impact factor: 4.849

Review 9.  Newest aspects on the association between migraine and cardiovascular disease: the role of modifying factors.

Authors:  Tobias Kurth; Markus Schürks
Journal:  Curr Pain Headache Rep       Date:  2009-06

Review 10.  Migraine and stroke: from a questioned relationship to a supported comorbidity.

Authors:  Maria Carola Narbone; Santo Gangemi; Maria Abbate
Journal:  Neurol Sci       Date:  2008-05       Impact factor: 3.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.